These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11849316)

  • 1. Murine graft-versus-host disease induced using interferon-gamma-deficient grafts features antibodies to double-stranded DNA, T helper 2-type cytokines and hypereosinophilia.
    Ellison CA; Bradley DS; Fischer JM; Hayglass KT; Gartner JG
    Immunology; 2002 Jan; 105(1):63-72. PubMed ID: 11849316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
    Ellison CA; Fischer JM; HayGlass KT; Gartner JG
    J Immunol; 1998 Jul; 161(2):631-40. PubMed ID: 9670937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
    Murphy WJ; Welniak LA; Taub DD; Wiltrout RH; Taylor PA; Vallera DA; Kopf M; Young H; Longo DL; Blazar BR
    J Clin Invest; 1998 Nov; 102(9):1742-8. PubMed ID: 9802888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of interferon-gamma, nitric oxide and lipopolysaccharide in intestinal graft-versus-host disease developing in F1-hybrid mice.
    Ellison CA; Natuik SA; McIntosh AR; Scully SA; Danilenko DM; Gartner JG
    Immunology; 2003 Jul; 109(3):440-9. PubMed ID: 12807491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.
    Yang YG; Dey BR; Sergio JJ; Pearson DA; Sykes M
    J Clin Invest; 1998 Dec; 102(12):2126-35. PubMed ID: 9854048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of graft-versus-host disease by interleukin-2 treatment is associated with altered cytokine production by expanded graft-versus-host-reactive CD4+ helper cells.
    Wang MG; Szebeni J; Pearson DA; Szot GL; Sykes M
    Transplantation; 1995 Sep; 60(5):481-90. PubMed ID: 7676498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production.
    Xiao ZY; Zhou WX; Zhang YX; Cheng JP; He JF; Yang RF; Yun LH
    Life Sci; 2007 Oct; 81(19-20):1403-10. PubMed ID: 17950363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease.
    Kuroiwa T; Iwasaki T; Imado T; Sekiguchi M; Fujimoto J; Sano H
    Arthritis Res Ther; 2006; 8(4):R123. PubMed ID: 16859527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma is not involved in the intestinal manifestations of the acute murine semiallogenic graft-versus-host disease.
    Stüber E; Schlenger P; Von Freier A; Arendt T; Fölsch UR
    Int J Colorectal Dis; 2001 Sep; 16(5):346-51. PubMed ID: 11686535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early delayed-type hypersensitivity eosinophil infiltrates depend on T helper 2 cytokines and interferon-gamma via CXCR3 chemokines.
    Akahira-Azuma M; Szczepanik M; Tsuji RF; Campos RA; Itakura A; Mobini N; McNiff J; Kawikova I; Lu B; Gerard C; Pober JS; Askenase PW
    Immunology; 2004 Mar; 111(3):306-17. PubMed ID: 15009431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine profiles in various graft-versus-host disease target organs following hematopoietic stem cell transplantation.
    Lai HY; Chou TY; Tzeng CH; Lee OK
    Cell Transplant; 2012; 21(9):2033-45. PubMed ID: 22840591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of palifermin in a murine model of graft-versus-host disease (GVHD) associated with Th2 cytokine production, autoantibody production, and glomerulonephritis.
    Ellison CA; Gibson IW; Hayglass KT; Gartner JG
    J Clin Immunol; 2006 Sep; 26(5):485-94. PubMed ID: 16952010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donors.
    Ellison CA; Taniguchi M; Fischer JM; Hayglass KT; Gartner JG
    Immunology; 2006 Nov; 119(3):338-47. PubMed ID: 16879624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease.
    Tanaka J; Imamura M; Kasai M; Zhu X; Kobayashi S; Imai K; Hashino S; Higa T; Sakurada K; Miyazaki T
    Bone Marrow Transplant; 1994 Nov; 14(5):695-701. PubMed ID: 7889002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute, lethal graft-versus-host disease in an F1-hybrid model using grafts from parental-strain, T-cell receptor-delta gene knockout donors.
    Ellison C; Gartner J
    Scand J Immunol; 1998 Sep; 48(3):272-6. PubMed ID: 9743212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced interferon-alpha/beta (IFN-alpha/beta) and defective IFN-gamma production in chronic graft versus host disease: a potential mechanism for immunosuppression.
    Cleveland MG; Lane RG; Klimpel GR
    Cell Immunol; 1987 Nov; 110(1):120-30. PubMed ID: 3119228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of in vivo administration of interferon (IFN)-gamma, anti-IFN-gamma, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease.
    Umland SP; Razac S; Nahrebne DK; Seymour BW
    Clin Immunol Immunopathol; 1992 Apr; 63(1):66-73. PubMed ID: 1591885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of natural killer cells from the graft reduces interferon-gamma levels and lipopolysaccharide-induced tumor necrosis factor-alpha release in F1 hybrid mice with acute graft-versus-host disease.
    Ellison CA; HayGlass KT; Fischer JM; Rector ES; MacDonald GC; Gartner JG
    Transplantation; 1998 Aug; 66(3):284-94. PubMed ID: 9721794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations.
    Carlson MJ; West ML; Coghill JM; Panoskaltsis-Mortari A; Blazar BR; Serody JS
    Blood; 2009 Feb; 113(6):1365-74. PubMed ID: 18957685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.